Company / Gross Profit
LivaNova Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$939.9M
FY2025
5-year range
$594.8M / $939.9M
FY2021-FY2025
Trend
+10.1%
vs FY2024
Sector context
#41 of 100
Health Care
What the data says
At $940M, LivaNova's gross profit ranks #41 of 100 in the Health Care sector. Gross Profit has increased for 3 consecutive years, from $595M in FY2022 to $940M in FY2025.
Based on SEC 10-K filings.
$940M in FY2025 with a 5-year CAGR of +9.6%.
Improved from $756M to $940M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +16.5%
- 5-Year CAGR
- +9.6%
- 10-Year CAGR
- -
Sector benchmark
#41 of 100 in Health CareTop 41% of 100This company $939.9M Sector average $1.8B
▼
-48.3% below sector average
Key checks
Key Insights
- LivaNova's gross profit has grown for 3 consecutive years.
- 5-year CAGR of +9.6%, indicating consistent growth.
- In FY2025, gross profit increased 10.1% year-over-year.
- Ranks #41 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $939.9M | +10.1% |
| FY2024 | $853.5M | +12.9% |
| FY2023 | $755.8M | +27.1% |
| FY2022 | $594.8M | -17.8% |
| FY2021 | $723.8M | +21.7% |
| FY2020 | $594.8M | -17.8% |
| FY2019 | $723.8M | +346.6% |
| FY2018 | $162.1M | +9.8% |
| FY2017 | $147.6M | -73.6% |
| FY2016 | $559.5M | +124.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026